GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
3439.6000 137.70 (4.17%)
NSE Jun 27, 2025 15:56 PM
Volume: 499.0K
High volume today

logo
GlaxoSmithKline Pharmaceuticals Ltd.
24 Oct 2018
3439.60
4.17%
buy
by Karvy
Target: 1033
Karvy
Revenue growth impacted by GST: Revenues for the quarter at Rs 8163 mn were below our estimates of Rs 8613 mn. The operating margins at 20.2% in Q2FY19 were below our estimates of 24%.
 
GlaxoSmithKline Pharmaceuticals Ltd. has gained 16.18% in the last 1 Month
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended
Market closes higher, Ahluwalia bags Rs 1,103.6 crore residential projects in Gurugram and Bengaluru
Trendlyne Marketwatch | 27 Jun 2025, 03:57PM
Smallcaps are back on the radar, with promising growth | Screener: Analyst favourites among smallcaps
The Baseline | 26 Jun 2025, 12:56PM
Chart of the Week: Rising demand and capacity expansion to power earnings and revenue growth for Q1FY26
The Baseline | 26 Jun 2025, 12:33PM